Literature DB >> 16847816

Structure activity relationship studies on the antimicrobial activity of novel edeine A and D analogues.

Zbigniew Czajgucki1, Ryszard Andruszkiewicz, Wojciech Kamysz.   

Abstract

Edeines are pentapeptide amide antibiotics composed of four nonprotein amino acids, glycine, and polyamine. They exhibit antimicrobial and immunosuppressive activities and are universal inhibitors of translation. Moreover, it was proven that the free ionizable carboxy group in the (2R, 6S, 7R)-2,6-diamino-7-hydroxyazelaic acid moiety is not essential for biological activity of these compounds. In this paper we describe the synthesis of four novel edeine A and D analogues in which the above-mentioned acid residue was replaced with the (3R, 4S)- or (3S, 4S)-4,5-diamino-3-hydroxypentanoic acid moiety. In one compound we also introduced into molecule the 3-N,N-dimethyl derivative of (S)-2,3-diaminopropanoic acid to prevent the transpeptidation process, which results in the loss of biological activity of alpha-isomers of edeines. All peptides were synthesized applying the active ester and azide methods and on the basis of the coupling of suitable N-terminal tripeptides with proper C-terminal dipeptide amides. The activities of the newly obtained edeine analogues against selected strains of bacteria and fungi are also presented. Copyright 2006 European Peptide Society and John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847816     DOI: 10.1002/psc.775

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  6 in total

1.  Diversity of monomers in nonribosomal peptides: towards the prediction of origin and biological activity.

Authors:  Ségolène Caboche; Valérie Leclère; Maude Pupin; Gregory Kucherov; Philippe Jacques
Journal:  J Bacteriol       Date:  2010-08-06       Impact factor: 3.490

Review 2.  Antimicrobial peptides produced by Brevibacillus spp.: structure, classification and bioactivity: a mini review.

Authors:  Xu Yang; Ahmed E Yousef
Journal:  World J Microbiol Biotechnol       Date:  2018-03-29       Impact factor: 3.312

3.  Draft genome sequence of Brevibacillus brevis strain X23, a biocontrol agent against bacterial wilt.

Authors:  Wu Chen; Yunsheng Wang; Dingjun Li; Lin Li; Qiming Xiao; Qingming Zhou
Journal:  J Bacteriol       Date:  2012-12       Impact factor: 3.490

4.  The immunoregulatory effects of edeine analogues in mice.

Authors:  Zbigniew Czajgucki; Michał Zimecki; Ryszard Andruszkiewicz
Journal:  Cell Mol Biol Lett       Date:  2006-12-05       Impact factor: 5.787

5.  Draft Genome Sequence of Biocontrol Bacterium Brevibacillus brevis Strain FJAT-0809-GLX.

Authors:  Jianmei Che; Bo Liu; Yingzhi Lin; Weiqi Tang; Jianyang Tang
Journal:  Genome Announc       Date:  2013-04-25

6.  Enhancement of edeine production in Brevibacillus brevis X23 via in situ promoter engineering.

Authors:  Qingshu Liu; Liang Zhang; Yunsheng Wang; Cuiyang Zhang; Tianbo Liu; Caichen Duan; Xiaoying Bian; Zhaohui Guo; Qingshan Long; Ying Tang; Jie Du; Aiyu Liu; Liangying Dai; Dingjun Li; Wu Chen
Journal:  Microb Biotechnol       Date:  2021-07-26       Impact factor: 5.813

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.